Mobix Labs vs Silynxcom
MOBX and SYNX side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MOBX and SYNX compare
Silynxcom grew revenue faster over the last twelve months (−36.2% versus −49.8% for Mobix Labs).
Mobix Labs scores higher on the StockData Score (5 against 1 for Silynxcom), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MOBX | SYNX |
|---|---|---|
| Size and price | ||
| Market cap | $9.8M | – |
| Share price | $0.576 | $0.825 |
| Change, 1 year | −91.0% | −43.1% |
| Change, 5 years | −99.4% | – |
| Beta (5Y) | −0.20 | 1.20 |
| Employees | 46 | 36 |
| StockData Score | ||
| Total score | 5 (better) | 1 |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.8× | – |
| P/B | 1.6× | – |
| Fair value | $2.32 | – |
| Margin of safety | 75.2% | – |
| Growth | ||
| Revenue growth (TTM) | −49.8% | −36.2% (better) |
| Profitability | ||
| Gross margin | 33.0% | 36.3% (better) |
| Operating margin | −534% | −52.2% (better) |
| Net margin | −879% | – |
| FCF margin | – | −46.4% |
| Return on equity | −1454% | – |
| Return on invested capital | −421% | – |
| Financial health | ||
| Debt / equity | 0.38 | – |
| Interest coverage | −6.0× (better) | −29.2× |
| Current ratio | 0.27 | 3.11 (better) |
| Altman Z-score | −10.31 | – |
| Piotroski F-score | 5 | – |
| Dividends and buybacks | ||
| Buyback yield | −23.1% | – |
| Shareholder yield | −23.1% | – |
| Ownership | ||
| Held by institutions | 14.9% | – |
| Held by insiders | 46.2% | 54.6% |
| Insider net buying, 12 months | −$349K | $157K (better) |
| Short interest, % of float | – | 0.24% |
Go deeper
- MOBX stock overview
- MOBX income statement
- MOBX valuation and score
- SYNX stock overview
- SYNX income statement
- SYNX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.